• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form NT 10-Q filed by DIH Holdings US Inc.

    8/15/25 8:00:23 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care
    Get the next $DHAI alert in real time by email
    NT 10-Q 1 formnt10-q.htm NT 10-Q

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 12b-25

     

      NOTIFICATION OF LATE FILING SEC FILE NUMBER
    001-41250
         
        CUSIP NUMBER
        23290B 106

     

    (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D Form N-CEN ☐ Form N-CSR

     

    For Period Ended: June 30, 2025

     

      ☐ Transition Report on Form 10-K

     

      ☐ Transition Report on Form 20-F

     

      ☐ Transition Report on Form 11-K

     

      ☐ Transition Report on Form 10-Q

     

    For the Transition Period Ended: _______________

     

    Read Instruction (on back page) Before Preparing Form. Please Print or Type.

    Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

     

    If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

     

    PART I – REGISTRANT INFORMATION

     

    DIH Holding US, Inc.

    Full Name of Registrant

     

    Aurora Technology Acquisition Corp.

    Former Name if Applicable

     

    77 Accord Park Drive; Suite D-1

    Address of Principal Executive Office (Street and Number)

     

    Norwell, MA 02061

    City, State and Zip Code

     

     

     

     

     

     

    PART II – RULES 12b-25(b) AND (c)

     

    If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

     

      (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
    ☐ (b) The subject annual report, semi-annual report, transition report on Form10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
      (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

     

    PART III – NARRATIVE

     

    State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

     

    The Registrant has determined that it is unable, without unreasonable effort or expense, to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 by the prescribed due date because it requires additional time to finalize its financial statements and disclosures to be included in such Form 10-Q. The Registrant has not yet filed its Annual Report on Form 10-K for the fiscal year ended March 31, 2025 (the “Form 10-K”) and is working to complete all steps and tasks necessary to finalize the financial statements and other disclosures required to be included in the Form 10-K. The Registrant does not anticipate being able to file the Form 10-Q within the extension period provided by Rule 12b-25.

     

    PART IV – OTHER INFORMATION

     

    (1) Name and telephone number of person to contact in regard to this notification

     

    Lynden Bass   (781)   424-1942
    (Name)   (Area Code)   (Telephone Number)

     

    (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?  If answer is no, identify report(s). ☐ Yes ☒ No
      Annual Report on Form 10-K for the fiscal year ended March 31, 2025  
         
    (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☐ Yes ☒ No

     

      If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

     

     
     

     

    DIH HOLDING US, INC.

    (Name of Registrant as Specified in Charter)

     

    has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: August 15, 2025 By: /s/ Lynden Bass
      Name: Lynden Bass
      Title: Chief Financial Officer

     

    INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

     

      ATTENTION  
       
    Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

     

     

     

     

    Get the next $DHAI alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DHAI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DHAI
    SEC Filings

    View All

    SEC Form DEF 14A filed by DIH Holdings US Inc.

    DEF 14A - DIH HOLDING US, INC. (0001883788) (Filer)

    8/26/25 9:15:24 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    SEC Form NT 10-Q filed by DIH Holdings US Inc.

    NT 10-Q - DIH HOLDING US, INC. (0001883788) (Filer)

    8/15/25 8:00:23 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    SEC Form PRE 14A filed by DIH Holdings US Inc.

    PRE 14A - DIH HOLDING US, INC. (0001883788) (Filer)

    8/13/25 9:00:04 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Burell Scott R claimed no ownership of stock in the company (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    8/11/25 4:05:17 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    New insider Streppa Dennis claimed ownership of 78,022 shares (SEC Form 3)

    3 - DIH HOLDING US, INC. (0001883788) (Issuer)

    7/25/25 4:30:13 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    Director Baucus Max was granted 52,817 shares (SEC Form 4)

    4 - DIH HOLDING US, INC. (0001883788) (Issuer)

    12/9/24 4:03:26 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Scott R. Burell to its Board of Directors. Scott R. Burell is a seasoned healthcare finance executive with over two decades of experience leading public life sciences companies through complex transactions and growth phases. Currently serving as Chief Financia

    8/8/25 8:00:00 AM ET
    $DHAI
    $MBOT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    DIH Holding US, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K

    NORWELL, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH" or the "Company") (NASDAQ:DHAI) received a notice on July 29, 2025, from the Listing Qualifications Staff of The Nasdaq Stock Market LLC ("Nasdaq"), which stated that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) because it had not filed its Annual Report on Form 10-K for the period ended March 31, 2025 with the Securities and Exchange Commission ("SEC"). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the SEC. Under Nasdaq rules, the Company has 60 calendar days from the date of the notice to file its Annual Report on F

    8/1/25 4:30:00 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Appoints Dennis Streppa to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Dennis Streppa to its Board of Directors and filling the Audit Committee Chair position. Dennis Streppa is a seasoned global Chief Operations Officer and entrepreneur with expertise spanning public and private healthcare companies. He's driven M&A value at Cardi

    7/18/25 5:00:56 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

    SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

    11/14/24 6:07:49 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by DIH Holdings US Inc.

    SC 13G/A - DIH HOLDING US, INC. (0001883788) (Subject)

    11/14/24 12:46:18 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D filed by DIH Holdings US Inc.

    SC 13D - DIH HOLDING US, INC. (0001883788) (Subject)

    2/20/24 5:18:47 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    $DHAI
    Leadership Updates

    Live Leadership Updates

    View All

    DIH Appoints Scott R. Burell to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Scott R. Burell to its Board of Directors. Scott R. Burell is a seasoned healthcare finance executive with over two decades of experience leading public life sciences companies through complex transactions and growth phases. Currently serving as Chief Financia

    8/8/25 8:00:00 AM ET
    $DHAI
    $MBOT
    Medical/Dental Instruments
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    DIH Appoints Dennis Streppa to DIH Holding US, Inc. Board of Directors

    NORWELL, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Dennis Streppa to its Board of Directors and filling the Audit Committee Chair position. Dennis Streppa is a seasoned global Chief Operations Officer and entrepreneur with expertise spanning public and private healthcare companies. He's driven M&A value at Cardi

    7/18/25 5:00:56 PM ET
    $DHAI
    Medical/Dental Instruments
    Health Care

    DIH Appoints Professor Nick Ward, M.D., to DIH Scientific Advisory Board

    NORWELL, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- DIH Holding US, Inc. ("DIH")(NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Professor Nick Ward, M.D. to its Scientific Advisory Board. Nick Ward, M.D., is a Professor of Clinical Neurology and Neurorehabilitation at the Institute of Neurology at University College London and at the National Hospital for Neurology and Neurosurgery in Lo

    7/15/25 8:00:00 AM ET
    $DHAI
    Medical/Dental Instruments
    Health Care